http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2350697-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_572c183eff7ef156ff244e4a2cc817ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b90cbf86ebafdd873cb70a31c09c26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2abf606228a637fca6148ad652606986 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_373fc0b69ec75ab3d492fce5d6879e1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba6dd73d289382978b01252e3f70b21e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a04712fb33f4b0c6c0af0397e770d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31aaacf5ee87953c6ab2ae3940f8fbf0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efabf6f172de2462a9da6b70c62853dc |
| publicationDate | 2011-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2350697-T3 |
| titleOfInvention | PIRROLOTRIAZINE COMPOUNDS. |
| abstract | A compound of formula I: ** (See formula) ** in which: R 1 is hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, carbocyclic ring, substituted carbocyclic ring, aryl, substituted aryl, heterocyclyl or substituted heterocyclyl; said substituents on the substituted alkyl, cycloalkyl, aryl or heterocyclyl selected from the group consisting of one or more of hydrogen, halogen, alkyl, substituted alkyl, aryl, substituted aryl, heterocyclyl, substituted heterocyclyl, -CN, -N3, -NH2, -NH-alkyl, -NH-substituted alkyl, -NH-aryl, -NH-substituted aryl, -NHCO-alkyl, imino, alkylimino, substituted alkylimino, arylimino, substituted arylimino, hydroxy, alkoxy, substituted alkoxy, aryloxy, substituted aryloxy , carboxy, -CONH-alkyl, -CONH-substituted alkyl, R2 is aryl, substituted aryl, heterocyclyl or substituted heterocyclyl; said substituents in the substituted aryl or substituted heterocyclyl group are selected from the group consisting of one or more of: hydrogen, halogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, -CN, - N3, alkoxy, substituted alkoxy, aryl, substituted aryl, aryloxy, substituted aryloxy, -O-heterocyclyl, -O-substituted heterocyclyl, heterocyclyl, substituted heterocyclyl, -CF3 and &8211;OCF3; X is a direct bond or NH- or a pharmaceutically acceptable salt, ester, solvate, prodrug or stereoisomer thereof. |
| priorityDate | 2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 498.